Filana Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Filana Therapeutics, Inc. (FLNA) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 39.41 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-01
- Filana Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 39.97M shares, a 32.40% increase year-over-year.
- Filana Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 39.96M shares, a 60.01% increase year-over-year.
- Filana Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 39.95M shares, a 61.24% increase year-over-year.
- Filana Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 37.72M shares, a 54.08% increase year-over-year.
- Filana Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 39.41M shares, a 50.95% increase from fiscal 2020.
- Filana Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 26.11M shares, a 49.93% increase from fiscal 2019.
- Filana Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 17.41M shares, a 63.00% increase from fiscal 2018.
- Filana Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 10.68M shares, a 63.41% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | 39.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 39.96M shares derived: average of 2 quarters · filed 2022-03-01 | 39.96M shares derived: average of 3 quarters · filed 2022-03-01 | 39.41M shares 10-K · filed 2022-03-01 | ||||
| 2021-09-30 | 39.96M shares 10-Q · filed 2021-11-15 | 39.95M shares derived: average of 2 quarters · filed 2021-11-15 | 39.22M shares 10-Q · filed 2021-11-15 | 36.95M shares derived: average of 4 quarters · filed 2022-03-01 | ||||
| 2021-06-30 | 39.95M shares 10-Q · filed 2021-08-04 | 38.84M shares 10-Q · filed 2021-08-04 | 35.95M shares derived: average of 3 quarters · filed 2022-03-01 | 33.21M shares derived: average of 4 quarters · filed 2022-03-01 | ||||
| 2021-03-31 | 37.72M shares 10-Q · filed 2021-04-29 | 33.95M shares derived: average of 2 quarters · filed 2022-03-01 | 30.96M shares derived: average of 3 quarters · filed 2022-03-01 | 29.41M shares derived: average of 4 quarters · filed 2022-03-01 | ||||
| 2020-12-31 | 30.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 27.58M shares derived: average of 2 quarters · filed 2022-03-01 | 26.65M shares derived: average of 3 quarters · filed 2022-03-01 | 26.11M shares 10-K · filed 2022-03-01 | ||||
| 2020-09-30 | 24.97M shares 10-Q · filed 2021-11-15 | 24.88M shares derived: average of 2 quarters · filed 2021-11-15 | 24.75M shares 10-Q · filed 2021-11-15 | 23.10M shares derived: average of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | 24.78M shares 10-Q · filed 2021-08-04 | 24.63M shares 10-Q · filed 2021-08-04 | 22.47M shares derived: average of 3 quarters · filed 2021-08-04 | 21.15M shares derived: average of 4 quarters · filed 2021-08-04 | ||||
| 2020-03-31 | 24.48M shares 10-Q · filed 2021-04-29 | 21.32M shares derived: average of 2 quarters · filed 2021-04-29 | 19.93M shares derived: average of 3 quarters · filed 2021-04-29 | 19.24M shares derived: average of 4 quarters · filed 2021-04-29 | ||||
| 2019-12-31 | 18.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | 17.66M shares derived: average of 2 quarters · filed 2021-03-23 | 17.50M shares derived: average of 3 quarters · filed 2021-03-23 | 17.41M shares 10-K · filed 2021-03-23 | ||||
| 2019-09-30 | 17.16M shares 10-Q · filed 2020-11-09 | 17.16M shares derived: average of 2 quarters · filed 2020-11-09 | 17.16M shares 10-Q · filed 2020-11-09 | 17.18M shares derived: average of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | 17.16M shares 10-Q · filed 2020-08-12 | 17.16M shares 10-Q · filed 2020-08-12 | 17.19M shares derived: average of 3 quarters · filed 2020-08-12 | 15.88M shares derived: average of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | 17.16M shares 10-Q · filed 2020-05-06 | 17.20M shares derived: average of 2 quarters · filed 2020-05-06 | 15.45M shares derived: average of 3 quarters · filed 2020-05-06 | 13.30M shares derived: average of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | 17.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | 14.60M shares derived: average of 2 quarters · filed 2020-03-26 | 12.01M shares derived: average of 3 quarters · filed 2020-03-26 | 10.68M shares 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | 11.96M shares 10-Q · filed 2019-10-29 | 9.40M shares derived: average of 2 quarters · filed 2019-10-29 | 8.50M shares 10-Q · filed 2019-10-29 | 7.99M shares derived: average of 4 quarters · filed 2019-10-29 | ||||
| 2018-06-30 | 6.84M shares 10-Q · filed 2019-08-12 | 6.74M shares 10-Q · filed 2019-08-12 | 6.67M shares derived: average of 3 quarters · filed 2019-08-12 | 6.64M shares derived: average of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | 6.64M shares 10-Q · filed 2019-05-02 | 6.59M shares derived: average of 2 quarters · filed 2019-05-02 | 6.57M shares derived: average of 3 quarters · filed 2019-05-02 | 6.56M shares derived: average of 4 quarters · filed 2019-05-02 | ||||
| 2017-12-31 | 6.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | 6.54M shares derived: average of 2 quarters · filed 2019-03-29 | 6.54M shares derived: average of 3 quarters · filed 2019-03-29 | 6.54M shares 10-K · filed 2019-03-29 | ||||
| 2017-09-30 | 6.54M shares 10-Q · filed 2018-10-30 | 6.54M shares derived: average of 2 quarters · filed 2018-10-30 | 6.54M shares 10-Q · filed 2018-10-30 | 6.54M shares derived: average of 4 quarters · filed 2018-10-30 | ||||
| 2017-06-30 | 6.54M shares 10-Q · filed 2018-07-26 | 6.54M shares 10-Q · filed 2018-07-26 | 6.54M shares derived: average of 3 quarters · filed 2018-07-26 | 6.54M shares derived: average of 4 quarters · filed 2018-07-26 | ||||
| 2017-03-31 | 6.54M shares 10-Q · filed 2018-05-09 | 45.74M shares 10-Q · filed 2017-04-26 | 6.54M shares derived: average of 2 quarters · filed 2018-05-09 | 6.54M shares derived: average of 3 quarters · filed 2018-05-09 | 6.53M shares derived: average of 4 quarters · filed 2018-05-09 | |||
| 2016-12-31 | 6.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-06 | 6.54M shares derived: average of 2 quarters · filed 2018-02-06 | 6.53M shares derived: average of 3 quarters · filed 2018-02-06 | 6.52M shares 10-K · filed 2018-02-06 | 45.64M shares 10-K · filed 2017-03-07 | |||
| 2016-09-30 | 6.54M shares 10-Q · filed 2017-11-01 | 45.74M shares 10-Q · filed 2016-10-26 | 6.53M shares derived: average of 2 quarters · filed 2017-11-01 | 6.51M shares 10-Q · filed 2017-11-01 | 45.60M shares 10-Q · filed 2016-10-26 | 25.94M shares derived: average of 4 quarters · filed 2017-11-01 | ||
| 2016-06-30 | 6.53M shares 10-Q · filed 2017-08-09 | 45.71M shares 10-Q · filed 2016-07-19 | 6.50M shares 10-Q · filed 2017-08-09 | 45.53M shares 10-Q · filed 2016-07-19 | 32.41M shares derived: average of 3 quarters · filed 2017-08-09 | 35.65M shares derived: average of 4 quarters · filed 2017-08-09 | ||
| 2016-03-31 | 45.36M shares 10-Q · filed 2017-04-26 | 45.36M shares derived: average of 2 quarters · filed 2017-04-26 | 45.36M shares derived: average of 3 quarters · filed 2017-04-26 | 45.36M shares derived: average of 4 quarters · filed 2017-04-26 | ||||
| 2015-12-31 | 45.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | 45.36M shares derived: average of 2 quarters · filed 2017-03-07 | 45.36M shares derived: average of 3 quarters · filed 2017-03-07 | 45.36M shares 10-K · filed 2017-03-07 | ||||
| 2015-09-30 | 45.36M shares 10-Q · filed 2016-10-26 | 45.36M shares derived: average of 2 quarters · filed 2016-10-26 | 45.36M shares 10-Q · filed 2016-10-26 | 45.36M shares derived: average of 4 quarters · filed 2017-03-07 | ||||
| 2015-06-30 | 45.36M shares 10-Q · filed 2016-07-19 | 45.36M shares 10-Q · filed 2016-07-19 | 45.36M shares derived: average of 3 quarters · filed 2017-03-07 | 45.35M shares derived: average of 4 quarters · filed 2017-03-07 | ||||
| 2015-03-31 | 45.36M shares 10-Q · filed 2016-05-05 | 45.36M shares derived: average of 2 quarters · filed 2017-03-07 | 45.35M shares derived: average of 3 quarters · filed 2017-03-07 | 45.33M shares derived: average of 4 quarters · filed 2017-03-07 | ||||
| 2014-12-31 | 45.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | 45.35M shares derived: average of 2 quarters · filed 2017-03-07 | 45.32M shares derived: average of 3 quarters · filed 2017-03-07 | 45.27M shares 10-K · filed 2017-03-07 | ||||
| 2014-09-30 | 45.34M shares 10-Q · filed 2015-11-09 | 45.30M shares derived: average of 2 quarters · filed 2015-11-09 | 45.24M shares 10-Q · filed 2015-11-09 | |||||
| 2014-06-30 | 45.25M shares 10-Q · filed 2015-07-23 | 45.19M shares 10-Q · filed 2015-07-23 | ||||||
| 2014-03-31 | 45.13M shares 10-Q · filed 2015-05-08 | |||||||
| 2013-09-30 | 45.04M shares 10-Q · filed 2014-11-05 | 45.02M shares derived: average of 2 quarters · filed 2014-11-05 | 44.99M shares 10-Q · filed 2014-11-05 | 259.50K shares derived: average of 4 quarters · filed 2014-11-05 | ||||
| 2013-06-30 | 45.00M shares 10-Q · filed 2014-08-06 | 44.97M shares 10-Q · filed 2014-08-06 | -14.67M shares derived: average of 3 quarters · filed 2014-08-06 | 150.50K shares derived: average of 4 quarters · filed 2014-08-06 | ||||
| 2013-03-31 | 44.93M shares 10-Q · filed 2014-05-07 | -44.50M shares derived: average of 2 quarters · filed 2014-05-07 | -14.80M shares derived: average of 3 quarters · filed 2014-05-07 | 95.00K shares derived: average of 4 quarters · filed 2014-05-07 | ||||
| 2012-12-31 | -133.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-08 | -44.66M shares derived: average of 2 quarters · filed 2013-11-01 | -14.85M shares derived: average of 3 quarters · filed 2013-11-01 | 44.75K shares 10-K · filed 2013-02-08 | ||||
| 2012-09-30 | 44.60M shares 10-Q · filed 2013-11-01 | 44.60K shares 10-Q · filed 2012-11-09 | 44.69M shares derived: average of 2 quarters · filed 2013-11-01 | 44.70M shares 10-Q · filed 2013-11-01 | 44.70K shares 10-Q · filed 2012-11-09 | |||
| 2012-06-30 | 44.78M shares 10-Q · filed 2013-08-01 | 44.78K shares 10-Q · filed 2012-08-02 | 44.75M shares 10-Q · filed 2013-08-01 | 44.75K shares 10-Q · filed 2012-08-02 | ||||
| 2011-12-31 | 44.68K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-08 | 44.66K shares derived: average of 2 quarters · filed 2013-02-08 | 44.50K shares derived: average of 3 quarters · filed 2013-02-08 | 44.16K shares 10-K · filed 2013-02-08 | ||||
| 2011-09-30 | 44.63K shares 10-Q · filed 2012-11-09 | 44.41K shares derived: average of 2 quarters · filed 2012-11-09 | 43.99K shares 10-Q · filed 2012-11-09 | |||||
| 2011-06-30 | 44.19K shares 10-Q · filed 2012-08-02 | 43.66K shares 10-Q · filed 2012-08-02 | ||||||
| 2010-12-31 | 42.64K shares 10-K · filed 2013-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |